For the quarter ending 2025-09-30, STXS had $3,539K increase in cash & cash equivalents over the period. -$4,204K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -6,463 | -9,649 |
| Depreciation | 156 | 312 |
| Amortization of intangibles | 233 | 459 |
| Loss on revaluation of contingent consideration | 1,352 | 458 |
| Non-cash lease expense | 1 | - |
| Stock-based compensation | 2,503 | 4,902 |
| Accounts receivable | 940 | 569 |
| Inventories | 539 | 1,277 |
| Prepaid expenses and other current assets | -258 | -913 |
| Other assets | 162 | 11 |
| Accounts payable | -2,077 | 1,062 |
| Accrued liabilities | 238 | -145 |
| Deferred revenue | 1,246 | -1,968 |
| Non-cash lease expense | - | 1 |
| Other liabilities | -9 | 0 |
| Net cash used in operating activities | -4,204 | -5,512 |
| Purchase of property and equipment | 0 | 23 |
| Net cash (used in) provided by investing activities | 0 | -23 |
| Proceeds from issuance of stock, net of issuance costs | 7,743 | 66 |
| Net cash provided by financing activities | 7,743 | 66 |
| Net decrease in cash, cash equivalents, and restricted cash | 3,539 | -5,469 |
| Cash and cash equivalents at beginning of period | 12,436 | - |
| Cash and cash equivalents at end of period | 10,506 | - |
Stereotaxis, Inc. (STXS)
Stereotaxis, Inc. (STXS)